Cardiology
From the Journals
Myocarditis higher with Moderna COVID vax in young men
Increased risk for myocarditis was seen with both mRNA vaccines in young men, and for the first time suggested a higher risk from vaccination than...
Conference Coverage
Young and older athletes show similar arrhythmia patterns with fQRS
Some structural changes were observed, but had no impact on exercise-induced arrhythmias in adolescent athletes.
Conference Coverage
Peripheral muscle fatigue limits post-COVID exercise
Cardiopulmonary exercise testing suggests need for aerobic and muscle strengthening after COVID-19.
Pearl of the Month
What’s the most likely cause of this man’s severe headaches?
A 35-year-old man is suddenly experiencing severe headaches, which get worse with standing and resolve after lying down.
Latest News
Real-world data suggest coprescribing PDE5 inhibitors and nitrates may be safe
There is a scarcity of real-world data showing that using the two types of drugs together increase cardiovascular risks, according to researchers...
From the Journals
Bariatric surgery cuts cardiovascular events, even in seniors
In persons with obesity, even those aged 65-75 years of age, bariatric surgery can reduce long-term cardiovascular events, such as heart failure,...
From the Journals
Fresh data confirm healthy plant foods link to lower diabetes risk
Metabolites contained in whole grains, fruits, and vegetables seem to be the key to reducing risk of developing type 2 diabetes in those who...
From the Journals
Aged black garlic supplement may help lower BP
“ABG that is much more highly concentrated than fresh or processed garlic might be helpful in lowering BP in certain subgroups.”
From the Journals
The best statins to lower non-HDL cholesterol in diabetes?
Rosuvastatin, simvastatin, and atorvastatin were most effective in reducing levels of non-HDL cholesterol in people with diabetes in a network...
From the Journals
Aspirin exposure fails to reduce cardiovascular event risk
Post hoc analysis showed no additional benefit from aspirin in reducing cardiovascular risk for hypertension patients with controlled systolic...
Conference Coverage
Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class...